New evidence for Ivermectin use in Covid-19, but Sahpra won’t budge
Medicines body maintains the quality of trials on the efficacy of Ivermectin in Covid‐19 patients is poor and underpowered.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
